These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7251503)

  • 1. Structures of siomycin-B and -C and thiostrepton-B determined by NMR spectroscopy and carbon-13 signal assignments of siomycins, thiostreptons, and thiopeptin-B.
    Tori K; Tokura K; Yoshimura Y; Terui Y; Okabe K; Otsuka H; Matsushita K; Inagaki F; Miyazawa T
    J Antibiot (Tokyo); 1981 Jan; 34(1):124-9. PubMed ID: 7251503
    [No Abstract]   [Full Text] [Related]  

  • 2. 13C NMR study of thiostrepton and thiopeptin components.
    Hensens OD; Albers-Schönberg G
    J Antibiot (Tokyo); 1983 Jul; 36(7):832-45. PubMed ID: 6885637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reexamination of the 1H and 13C NMR spectral assignments of thiostrepton.
    Mocek U; Beale JM; Floss HG
    J Antibiot (Tokyo); 1989 Nov; 42(11):1649-52. PubMed ID: 2584149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H NMR spectral evidence for the structure and conformation of peptide antibiotic siomycin-A.
    Tori K; Tokura K; Yoshimura Y; Okabe K; Otsuka H; Inagski F; Miyazawa T
    J Antibiot (Tokyo); 1979 Oct; 32(10):1072-7. PubMed ID: 528371
    [No Abstract]   [Full Text] [Related]  

  • 5. The solution conformation of the peptide antibiotic thiostrepton: a 1H NMR study.
    Hensens OD; Albers-Schönberg G; Anderson BF
    J Antibiot (Tokyo); 1983 Jul; 36(7):799-813. PubMed ID: 6885635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tsr gene-coding plasmid pIJ702 prevents thiopeptin from inhibiting ppGpp synthesis in Streptomyces lividans.
    Ochi K
    FEMS Microbiol Lett; 1989 Oct; 52(1-2):219-23. PubMed ID: 2599357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-soluble siomycin-A derivatives. Preparation, chemical structures and biological properties of half-esters of the peptide antibiotic.
    Tokura K; Hayashi K; Okabe K; Tori K; Yoshimura Y; Mayama M; Matsuura S; Otsuka H
    J Antibiot (Tokyo); 1981 Jul; 34(7):800-10. PubMed ID: 7287582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-dimensional NMR spectroscopy of siomycin A. Proton--carbon-13 chemical shift correlation.
    Clayden NJ; Inagaki F; Williams RJ; Morris GA; Tori K; Tokura K; Miyazawa T
    Eur J Biochem; 1982 Mar; 123(1):127-31. PubMed ID: 6279393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptomyces laurentii, a new species producing thiostrepton.
    Trejo WH; Dean LD; Pluscec J; Meyers E; Brown WE
    J Antibiot (Tokyo); 1977 Aug; 30(8):639-43. PubMed ID: 908663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthetic studies on validamycins. I. 1H and 13C NMR assignments of validamycin A.
    Jin WZ; Rinehart KL; Toyokuni T
    J Antibiot (Tokyo); 1987 Mar; 40(3):329-39. PubMed ID: 3570986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total structure of the highly modified peptide antibiotic components of thiopeptin.
    Hensens OD; Albers-Schönberg G
    J Antibiot (Tokyo); 1983 Jul; 36(7):814-31. PubMed ID: 6885636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon-13 NMR studies of EM 49 and related octapeptins.
    Puar MS
    J Antibiot (Tokyo); 1980 Jul; 33(7):760-3. PubMed ID: 7410218
    [No Abstract]   [Full Text] [Related]  

  • 13. L11 domain rearrangement upon binding to RNA and thiostrepton studied by NMR spectroscopy.
    Jonker HR; Ilin S; Grimm SK; Wöhnert J; Schwalbe H
    Nucleic Acids Res; 2007; 35(2):441-54. PubMed ID: 17169991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoline derivatives as degradation products from antibiotic thiopeptin B.
    Muramatsu I; Hikawa E; Hagitani A; Miyairi N
    J Antibiot (Tokyo); 1972 Sep; 25(9):537-8. PubMed ID: 4645950
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the ionophorous antibiotics. XXVI. The assignments of the 13C-NMR spectra of lonomycin A and mutalomycin.
    Seto H; Mizoue K; Otake N
    J Antibiot (Tokyo); 1980 Sep; 33(9):979-88. PubMed ID: 7440419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structures of fortimicins C, D, and KE.
    Iida T; Sato M; Matsubara I; Mori Y; Shirahata K
    J Antibiot (Tokyo); 1979 Dec; 32(12):1273-9. PubMed ID: 541253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effect of antibiotic siomycin on antibody production.
    Ueno M; Furukawa S; Abe F; Ushioda M; Fujine K; Johki S; Hatori H; Ueda H
    J Antibiot (Tokyo); 2004 Sep; 57(9):590-6. PubMed ID: 15580960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azinomycins A and B, new antitumor antibiotics. II. Chemical structures.
    Yokoi K; Nagaoka K; Nakashima T
    Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4554-61. PubMed ID: 3829181
    [No Abstract]   [Full Text] [Related]  

  • 19. Biphenomycins A and B, novel peptide antibiotics. II. Structural elucidation of biphenomycins A and B.
    Uchida I; Shigematsu N; Ezaki M; Hashimoto M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1985 Nov; 38(11):1462-8. PubMed ID: 3841123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by siomycin and thiostrepton of both aminoacyl-tRNA and factor G binding to ribosomes.
    Modolell J; Cabrer B; Parmeggiani A; Vazquez D
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1796-800. PubMed ID: 4331558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.